haylaavo

ALIVUS LIFE SCIENCES

ALIVUS · NSE
1,397.40
-2.00 (-0.14%)
as of 29 Oct 2026 close
Open
1,400.00
High
1,437.40
Low
1,385.00
Prev close
1,399.40
52w high
1,493.80
31 Aug 2026
52w low
819.00
22 Jan 2026
VWAP
1,406.64
Delivery %
54.0%
of volume
Volume 2.64 L · turnover ₹37.19 Cr · NSE bhavcopy (official close) · history since 20 Jan 2025
ISIN
INE03Q201024
Series
EQ
Listed on NSE
06 Aug 2021
Face value
₹2
F&O
No

Formerly GLS (until 20 Jan 2025). Earlier name: Glenmark Life Sciences Limited (until 20 Jan 2025).

Source: NSE equity master · as of 30 Oct 2026

Daily · NSE EOD
Moving averages & momentum · as of 29 Oct 2026 close
SMA 201,334.12
SMA 501,361.55
SMA 2001,120.66
RSI 1460.5
ATR 1454.69
How these are computed

SMA n = mean of last n daily closes. RSI 14 = Wilder smoothing of average gains/losses over 14 days. ATR 14 = Wilder average of true range (max of high−low, |high−prev close|, |low−prev close|). All from NSE end-of-day candles; nothing intraday.

52-week position · as of 29 Oct 2026 close
819.00 22 Jan 202686% of range1,493.80 31 Aug 2026
Returns · close to close
1w
+10.12%
1m
+3.86%
3m
+24.81%
6m
+38.68%
1y
+51.21%
Corporate actions · latest 6 · NSE
01 Sept 2026Dividend₹5/share
01 Sept 2025Dividend₹5/share
17 Oct 2023Dividend₹22.5/share
24 Mar 2023Dividend₹21/share
15 Sept 2022Dividend₹10.5/share
22 Nov 2021Dividend₹10.5/share

Ex-dates and subjects from NSE's corporate-actions feed; price-adjustment factors checked against the exchange's own prices. Charts use the adjusted series by default.